This morning, we had another new SPAC filing to add to the SPAC coffers with AGBA Acquisition Limited, a $40 million IPO. AGBA (whose letters are most likely an acronym of…something, but inevitably, you just wind up calling it “Aggg-Buhh”), will be focusing on businesses in China. Specifically, “….the healthcare, education, entertainment and financial services sectors“, which is pretty broad. So basically just China.
AGBA will be led by Gordon Lee, as Chief Executive Officer, and Vera Tan, as Chief Financial Officer. Looking at Mr. Lee’s bio in the prospectus, he is for sure an entrepreneur having founded a diverse number of businesses spanning education, gaming and even a music streaming application. Vera Tan, brings the requisite finance skills having worked in a variety of positions at Deutsche Bank, Mizuho and Goldman Sachs.
Looking at this SPAC’s structure, we see the typical terms used for a smaller China-focused deal. That is, 100% in trust, a unit with 1 warrant for 1/2 share, plus a right, and 12 months to find a combination. However, if AGBA needs to extend, they will will contribute $0.10 for each additional 3-month extension, of which, they are allowed three extensions (bringing the total duration to 21 months). However, we do have a small twist…
If you look at the underwriting fees, you will notice that Maxim will be receiving 2.5% for their upfront underwriting fee (at IPO) and an additional 4.0% is deferred until a successful combination. HOWEVER, there is an additional “success” layer built-in to the deferred fee. Essentially, the deferred underwriting fee will be reduced by $0.20 (or 2.0% of the gross proceeds) for each share that is redeemed by shareholders at the combination vote. Interesting.
So to sum up, the deferred underwriting fee is no longer just about “getting the combination closed”. Now, the underwriters are incentivized to get the combination closed AND with the maximum amount left in trust. The additional deferred fee of 2.0% is now based on the success of their capital markets capabilities at the de-SPACing. Having said that, the deferred underwriting fee is almost always negotiated away anyway (or paid in securities, etc.) in the event a SPAC is facing significant amounts of redemptions and this is basically just another way of stating that.
In theory, this seems like a pretty good way to incentivize the underwriters to get a SPAC over the finish line with a healthy amount of cash and float. However, it will be interesting to see how it plays out in real-time. The thing is, a good SPAC combo is a good SPAC combo and bad combo….well, it’s extremely difficult to get investors to buy no matter what the capital markets incentive is. Therefore, the real incentive is actually for the underwriters to make sure the SPAC team presents a great acquisition. That’s really what matters.
Summary of terms below:
At the SPAC of Dawn One more shoe has dropped as the President-Elect Donald Trump works to staff his incoming administration and set priorities as he has appointed Cantor Fitzgerald CEO Howard Lutnick to lead the Department of Commerce. This ends speculation about where the head of 2024’s leading SPAC underwriter would land. The question...
At the SPAC of Dawn Although the drought of new SPAC transactions is approaching one full month, that hasn’t stopped the dealmaking between de-SPACs themselves. Trump Media (NASDAQ:DJT) is reportedly in advanced talks to buy crypto and digital asset marketplace and 2021 de-SPAC Bakkt (NYSE:BKKT) in an all-stock deal, according to FT. The former target...
Columbus Acquisition Corp (NASDAQ:COLAU) has filed for a $57.5 million IPO to give its team a second vehicle in circulation to hunt for deals. The same team IPO’d Eureka (NASDAQ:EURK) in July at a slightly smaller $50 million scale and this new SPAC would improve upon some of that foray’s terms. Both SPACs managed to...
At the SPAC of Dawn One week before Thanksgiving, SPACs are not filling up their plate with just five votes scheduled, all of which are extensions. Five of these are set to take place today, and investors are also set to get an update on one of the most successful de-SPACs of recent years. Industrial...
Terms Tracker for the Week Ending November 15, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. The drought in De-SPAC deals continues without a single announced combination since October 23rd. That’s more than three weeks now with SPACs experiencing a dry...